Skip to content

AbCellera Biologics Inc. ABCL Distributions of earnings from equity method investees

Distributions of earnings from equity method investees at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$7.53M
McCormick & Company, Incorporated logo
McCormick & Company, IncorporatedMKC
$13.9M+67.5%
HNI logo
HNIHNI
$75K
Churchill Downs logo
Churchill DownsCHDN
$36M+16.1%
Realty Income logo
Realty IncomeO
$5.99M+4.1%
Digital Realty logo
Digital RealtyDLR
$22.41M+105%

Other financials

Income statement

See full
Revenue$8.3M+96.3%
Operating income-$57.5M+8.2%
Net income-$43.2M+5.4%
EPS (diluted)-$0.14+6.7%

Balance sheet

See full
Cash & equivalents$102.1M-44.6%
Total debt$140.2M+107%
Total equity$938.1M-8.3%
Total assets$1.3B-2.8%

Cash flow

See full
Operating cash flow-$33.5M-190%
CapEx$3.8M-64.0%
Free cash flow-$37.4M-68.3%

Valuation

See full
Market cap$1.72B+59.2%
Enterprise value$1.76B+100.0%
P/S21.7×-25.0×

Profitability

See full
Operating margin-267.6%-120pp
Net margin-181.7%-77.9pp
FCF margin-238.9%-90.9pp

Returns & leverage

See full
Return on equity-14.7%-0.8pp
Debt / equity0.1×+0.1×
Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestmentDividendsOrDistributions.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s distributions of earnings from equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbCellera Biologics Inc.'s distributions of earnings from equity method investees?
AbCellera Biologics Inc. (ABCL) reported distributions of earnings from equity method investees of $7.53M in Q4 2025.
What does distributions of earnings from equity method investees mean?
This metric tracks the cash distributions received from entities in which the company holds an equity interest but does not have full control. It represents the realized return on strategic partnerships and minority investments.